10.01.19
Kaneka Americas Holding, Inc. Newark, CA, has developed a new proprietary probiotic line, Floradapt. The unique clinical strains provide highly bio-efficacious effects for specific health applications through all stages of life, according to the company.
Kaneka has partnered with healthy lifestyle branding agency BrandHive, which will develop and implement marketing support for the product line.
“Our strategic collaboration with BrandHive will elevate our outreach and generate awareness of our new probiotic line, Floradapt,” said Mike Kolifrath, vice president of the Probiotics Division. “BrandHive has extensive knowledge and experience in the dietary supplements arena, and we are looking forward to optimizing our footprint and engaging with customers and partners in greater depth.”
Kaneka has an extensive bank of over 1,000 clinical probiotic strains extracted from human origin and fermented food samples which have not been affected by western lifestyle, diet or medicine. The new Floradapt line offers distinct solutions for diverse health targets such as children’s colic, cardio, digestive, oral, immune, vaginal and urinary tract fields.
“We are excited to represent Kaneka who has a rich history within the industry and is known as a leader in the research and development of scientifically based ingredients,” said Andy Yorkin, account director. “We look forward to supporting their growth in North America for this unique and innovative line of probiotics.”
Kaneka has partnered with healthy lifestyle branding agency BrandHive, which will develop and implement marketing support for the product line.
“Our strategic collaboration with BrandHive will elevate our outreach and generate awareness of our new probiotic line, Floradapt,” said Mike Kolifrath, vice president of the Probiotics Division. “BrandHive has extensive knowledge and experience in the dietary supplements arena, and we are looking forward to optimizing our footprint and engaging with customers and partners in greater depth.”
Kaneka has an extensive bank of over 1,000 clinical probiotic strains extracted from human origin and fermented food samples which have not been affected by western lifestyle, diet or medicine. The new Floradapt line offers distinct solutions for diverse health targets such as children’s colic, cardio, digestive, oral, immune, vaginal and urinary tract fields.
“We are excited to represent Kaneka who has a rich history within the industry and is known as a leader in the research and development of scientifically based ingredients,” said Andy Yorkin, account director. “We look forward to supporting their growth in North America for this unique and innovative line of probiotics.”
